Sijia Tao
- Virology top 5%
- HIV Research and Treatment 13
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 18
- HIV/AIDS Research and Interventions 4
- Hepatology top 10%
- Hepatitis C virus research 10
- Pharmacology top 5%
- Pharmacology top 10%
-
- Hepatitis B Virus Studies 7
- Cytomegalovirus and herpesvirus research 6
-
- Biochemical and Molecular Research 6
- Natural product bioactivities and synthesis 5
Sijia Tao
54 papers receiving 942 citations
Peers
Comparison fields: 5 of 97
- Virology 127
- Infectious Diseases 264
- Hepatology 97
- Pharmacology 84
- Pharmacology 147
Countries citing papers authored by Sijia Tao
This map shows the geographic impact of Sijia Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijia Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijia Tao more than expected).
Fields of papers citing papers by Sijia Tao
This network shows the impact of papers produced by Sijia Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijia Tao. The network helps show where Sijia Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sijia Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 13 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 19 | |
| 10 | 2019 | 46 | |
| 11 | 2018 | 6 | |
| 12 | 2017 | 62 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 2 | |
| 15 | 2014 | 10 | |
| 16 | 2014 | 1 | |
| 17 | 2012 | 18 | |
| 18 | 2011 | 11 | |
| 19 | 2010 | 6 | |
| 20 | 2010 | 105 |
About Sijia Tao
Sijia Tao is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 55 papers that have together received 960 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers), Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (7 papers), Biochemical and Molecular Research (6 papers), Cytomegalovirus and herpesvirus research (6 papers), Natural product bioactivities and synthesis (5 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Virology (127 citations), Infectious Diseases (264 citations) and Hepatology (97 citations). Sijia Tao has collaborated with scholars based in United States, China and Egypt. Frequent co-authors include Raymond F. Schinazi, Yong Jiang, De‐an Guo, Shuhong Guan, Franck Amblard, William R. Tyor, Christina Gavegnano, Woldeab B. Haile, Qing‐Xi Yue and Chun‐Ru Cheng. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.